Alba Therapeutics and the Univ of MD Report the Role of Zonulin and Intestinal Permeability in Celiac Disease
4th Nov 2005, 18:38 GMT
Today a team of scientists at Alba Therapeutics Corp and the Univ of MD School of Medicine reported a direct link between gluten-induced intestinal permeability and zonulin in tissues from patients with celiac disease.
Alba Therapeutics and the Univ of MD Report the Role of Zonulin and Intestinal Permeability in Celiac Disease related news:
- Intestinal symptoms vary for those with celiac disease — The Honolulu Advertiser: Island Life
- Greg Stiegmann, MD, named Interim Chancellor for Univ of CO at Denver and Health Sciences Center — Executive Announcements News from StratCenter.com
- Intestinal cancer drug breakthrough — the Mail online | Health news
- Study shows new drug delays intestinal cancer — USATODAY.com Health - Top Stories
- Drug delays intestinal cancer growth — News Elsewhere
- Introgen Therapeutics, Inc. geht Bündnis mit Colgate-Palmolive für Mundgesundheitspflege durch Nutzung von Introgens Molekulartherapien ein — Presseportal
- Drug May Slow Intestinal Cancer — CBS 2 Chicago WBBM-TV: Chicago news, weather, traffic, video: Health
- LifeMasters/Univ of Oregon Awarded Rsch Grant to Study Behavior Change Models in Disease Management — DBusiness News - San Francisco
- Teaching role for prison staff urged in report — Guardian Unlimited
- Sin City 2 Delayed? — Cinematical
Latest news from Pharmaceuticals News from StratCenter.com:
- Spectrum Pharmaceuticals to Receive $5 mln Milestone Payment From PAR Pharmaceutical for Sumatriptan Injection
- Medco to Present at the Credit Suisse Annual Healthcare Conference
- Bob Dole Medicare Podcast Helps Seniors through 2007 Drug Coverage Enrollment Process
- Unique Sugar Improves Energy, Pain and Quality of Life in Fibromyalgia and Chronic Fatigue Patients!
- Care Clinic Purchases Pinnacle Easy Care
- Pegasystems Enhances 2 Business Critical BPM Frameworks for the Healthcare Industry
- Isis Cholesterol Drug Shown Effective
- Taro Receives Marketing Authorization in UK for Etopan XL Tablets 600 mg, Etodolac
- Nymox Reports Q3 2006 Financial Results
- RemoteMDx Raises $6 mln in Private Placement